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ABSTRACT 
The present study deals with the development of an accurate, economical and reproducible UV spectrophotometric 
method for the simultaneous estimation of abacavir, lamivudine and zidovudine in pure bulk drug and in combined 
tablet dosage form. The stock solutions were prepared in acetonitrile followed by the further required dilutions with 
distilled water. The λ max for abacavir, lamivudine, and zidovudine were observed at 295.6, 279.8 and 266.2 nm 
respectively and linearity was also shown at these wavelengths in concentration range of 5-30 mg/ mL, 5-25mg/ mL 
and  5-30mg/mL  by  all  the  three  drugs.  Mixtures  containing  abacavir  -30  mg/mL,  lamivudine-15mg/mL  and 
zidovudine- 30mg/mL were analyzed at their respective wavelengths and using the simultaneous equations (Cramer’s 
rule), their contents were calculated.  
The  proposed  method  has  estimated  abacavir  99.25%,  lamivudine  99.12%  and  zidovudine  100.16%  in  standard 
mixture and 98.55%, 99.70 and 99.92% respectively  in the  marketed tablets. The results of  analysis  have  been 
validated  statistically  and  also  by  recovery  studies.  Thus  the  present  study  gives  an  excellent  method  for  the 
determination of all the three drugs in combined dosage formulation without their prior separation.  
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INTRODUCTION 
Abacavir  (ABA),  Lamivudine  (LAM),  and  Zidovudine 
(ZID) are Nucleoside analogs of anti HIV drugs. Several 
methods  including  spectrophotometric
1,2, HPLC
3,5-8 and 
HPTLC
4 methods have been reported for their estimation 
alone  or  with  other  drugs.    But  no  method  has  been 
found for their simultaneous estimation in selected fixed 
dose combination by UV spectrophotometric technique. 
MATERIALS AND METHODS 
Materials 
Shimadzu’s 1601 UV–visible spectrophotometer with a 
matched pair of 10mm quartz cells, ABA, LAM and ZID 
pure  drugs  (Cipla  Ltd.  Patalganga  and  Kurkumbh, 
INDIA), Acetonitrile (LOBA, India Ltd), distilled water 
and  tablets  containing  a  combination  of  ABA-300mg, 
LAM-150mg and ZID-300 mg were used in the present 
study.  
Methods 
1mg/mL stock solutions of the drugs were prepared in 
acetonitrile. For the linearity study, aliquots of the drug 
solutions were further diluted with distilled water to get 
the  final  working  standards  of  concentration  range  as 
ABA  -5-30  mg/  mL,  LAM  -5-25  mg/  mL  and  ZID-5-
30mg/  mL  respectively.  The  λ  max  for  abacavir, 
lamivudine,  and  zidovudine  were  observed  at  295.6, 
279.8  and  266.2  nm  respectively  and  the  calibration 
graphs were plotted at the respective wavelengths (Fig.1, 
2 and 3).  
For  the  proposed  method,  a  combination  of  drugs  in 
concentration  as  ABA  (30mg/  mL),  LAM  (15mg/  mL) 
and  ZID  (30mg/  mL)  was  selected  and  the  overlain 
spectrum  of  the  same  was  obtained  (Fig.4).Similarly, 
their mixture containing the same concentration was also 
scanned  and  measured  at  295.6,  279.8  and  266.2  nm 
respectively. From the absorbance values obtained of all 
the three drugs at all the three λ max, absorptivity values 
were calculated and are shown in Table 1.  
The content in the mixture was determined by using the 
following  three  component  equations/  Cramer’s  rule:Nagulwar Vaishali P et al / IJRAP 2011, 2 (2) 610-614 
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x component = A1 (β2 γ3 - β3 γ2)- A2(β1 γ3- β3 γ1)+ A3(β1 γ2- β2 γ1) /  
    α1((β2 γ3 - β3γ2)- α2(β1 γ3- β3 γ1)+ α3(β1 γ2- β2 γ1). 
 
Similarly, y and z component can be estimated.  
The  content  of  all  the  three  drugs  in  tablets  were 
estimated  by  same  procedure  after  dissolving  the 
appropriate quantity of tablet powder equivalent to 50mg 
of abacavir in acetonitrile in a 50 mL volumetric flask 
followed by vigorous shaking and filtering. The volume 
was made up to the mark and then aliquots diluted with 
distilled  water  containing  ABA  (30mg/  mL),  LAM 
(15mg/ mL) and ZID (30mg/ mL) were taken for analysis. 
The contents were calculated using the above mentioned 
formula. The results are shown in Table 2.  
The validity of the method was done by performing the 
recovery  studies  using  standard  addition  method.  The 
validation parameters are depicted in Table 3.  
RESULT AND DISCUSSION 
The  proposed  method  has  estimated  abacavir  99.25%, 
lamivudine 99.12% and zidovudine 100.16% in standard 
mixture and 98.55%, 99.70% and 99.92% respectively in 
the  marketed  tablets.  The  accuracy,  selectivity  and 
validity of the method were further assessed by applying 
the standard addition technique in the recovery studies, 
wherein  sample  was  spiked  with  known  quantity  of 
standard drug of ABA, LAM and ZID. The percentage 
recovery  was  found  to  be  ABA-  99.89  ±  0.05,  LAM-
99.52±  0.08  and  ZID-100.02  ±  0.03  respectively. 
Validation of the findings was carried out according to 
the ICH guidelines. 
The  main  advantage  of  the  proposed  method  is  its 
suitability for routine determination of ABA, LAM and 
ZID without their prior separation from marketed tablet 
formulations. The proposed method is economic, simple, 
most  sensitive,  precise  and  reproducible  and  do  not 
require  any  expensive  or  sophisticated  apparatus,  in 
contrast with the reported chromatographic methods. 
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Table 1: The absorptivity values of Abacavir, Lamivudine and Zidovudine in the proposed method. 
 
Absorptivity 
values 
 
Wavelength (nm) 
295.6  279.8  266.2 
ax1  456.66  -  - 
ax2  -  274.33  - 
ax3  -  -  255.33 
ay1  250  -  - 
ay2  -  546  - 
ay3  -  -  385.33 
az1  18  -  - 
az2  -  232.66  - 
az3  -  -  356.66 
 
* ax1, ax2 and ax3 are the absorptivity values of abacavir at the respective wavelengths. 
** ay1, ay2   and ay3 are the absorptivity values of lamivudine the respective wavelengths. 
*** az1, az2 and az3 are the absorptivity values of zidovudine the respective wavelengths. 
 
 Nagulwar Vaishali P et al / IJRAP 2011, 2 (2) 610-614 
 
International Journal of Research in Ayurveda & Pharmacy, 2(2), 2011  610-614 
 
Table 2:  The results of the analysis of commercial formulations and the recovery studies 
 
Standard 
mixture 
Concentration 
(µg/mL) 
Content 
estimated 
(µg/mL) 
% amount 
estimated 
Standard            
deviation   (± ) 
- 
ABA 
LAM 
ZID 
30 
15 
30 
29.78 
14.87 
30.05 
99.25 
99.12 
100.16 
0.204 
0.051 
0.208 
- 
- 
Tablet  Label claim 
(mg/tab) 
Amount found 
(mg/tab) 
%label claim  Standard 
deviation 
(±) 
% recovery 
± SD 
ABA 
LAM 
ZID 
 
300 
150 
300 
 
295.65 
149.55 
299.76 
98.55 
99.70 
99.92 
0.070 
0.474 
0.218 
 
99.88±0.05 
99.52±0.08 
100.02±0.03 
 
* All the values are the mean of five readings. 
 
Table 3: Regression analysis of Calibration curves and summary of validation parameters 
 
Parameters  ABA  LAM  ZID 
 
Wavelength (nm) 
Beer’s law limit(µg/mL) 
ε-Molar absorptivity (l/mol/cm) 
Limit of detection (µg/mL) 
Limit of quantitation (µg/mL)  
Sandell’s sensitivity (μg/cm
2) 
Regression equation* 
Intercept(α) 
Slope(β) 
Correlation coefficient(r) 
 
295.6 
5-30 
1.307563x 10
4 
1 
3 
0.02189813 
 
0.00428571 
0.04571429 
0.9999 
 
279.8 
5-25 
1.251759x10
4 
1 
2 
0.01831502 
 
-1.11022E-16 
0.0546 
1 
 
266.2 
5-30 
0.953138 x10
4 
2 
5 
0.02803791 
 
0.00025 
0.0356786 
0.9999 
 
Where, *y= α + β x, x is the concentration of the analyte and y is the absorbance value. 
 
Calibration graph of abacavir at 295.6nm.
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Fig.1: Calibration graph of abacavir at 295.6nm 
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Calibration graph of lamivudine at 279.8nm.
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Fig.2: Calibration graph of lamivudine at 279.8nm 
 
C alibration graph of zidovudine 
at266.2nm.
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Fig.3: Calibration graph of zidovudine at 266.2 nm 
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Fig.4. Overlain spectra of abacavir (30 m m m mg/mL), lamivudine (15m m m mg/ mL) and zidovudine (30m m m mg / mL) 
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